713479007: Ombitasvir (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Hepatitis C virus protein NS5A inhibitor\Ombitasvir
\Substance categorized by disposition\Substance with antiviral mechanism of action (substance)\Hepatitis C virus protein NS5A inhibitor\Ombitasvir

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Substance with antiviral mechanism of action (substance)\Hepatitis C virus protein NS5A inhibitor\Ombitasvir

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3289438013 Ombitasvir en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3289458014 Ombitasvir (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1833921000195114 ombitasvir it Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

829431000172110 ombitasvir fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ombitasvir	Is a	Hepatitis C virus protein NS5A inhibitor	true	Inferred relationship	Some
Ombitasvir	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Hepatitis C virus protein NS5A inhibitor (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing ombitasvir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ombitasvir	Inferred relationship	Some	1
Product containing ombitasvir and paritaprevir and ritonavir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ombitasvir	Inferred relationship	Some	2
Product containing ombitasvir and paritaprevir and ritonavir in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ombitasvir	Inferred relationship	Some	2
Product containing ombitasvir in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ombitasvir	Inferred relationship	Some	1
Product containing dasabuvir and ombitasvir and paritaprevir and ritonavir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ombitasvir	Inferred relationship	Some	2
Dasabuvir- and ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ombitasvir	Inferred relationship	Some	2
Dasabuvir and ombitasvir and paritaprevir and ritonavir only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ombitasvir	Inferred relationship	Some	2
Ombitasvir only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ombitasvir	Inferred relationship	Some	1
Ombitasvir and paritaprevir and ritonavir only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ombitasvir	Inferred relationship	Some	2
Product containing only ombitasvir and paritaprevir and ritonavir in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ombitasvir	Inferred relationship	Some	2
Product containing only ombitasvir in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ombitasvir	Inferred relationship	Some	1
Dasabuvir and ombitasvir and paritaprevir and ritonavir only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ombitasvir	Inferred relationship	Some	2
Product containing precisely ombitasvir 12.5 milligram and paritaprevir 75 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ombitasvir	Inferred relationship	Some	2
Product containing precisely ombitasvir 12.5 milligram and paritaprevir 75 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ombitasvir	Inferred relationship	Some	2

This concept is not in any reference sets